Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers
Award amount
$685,860Program and phase
STTR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PROTEIN METRICS INC
- Proposal award date
- 2014-09-22
- Contract end date
- 2016-08-31
- UEI
- D3ZDKNNU9PT9
- Solicitation number
- PA11-214
- Topic code
- 300
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Multistage LC-MSn for automated glycan isomer assignment of glycopeptides
- New Algorithms and Software for Mass Spectrometric Analysis of Intact Proteins and Complexes
- Integrated Platform for Mass-Spectrometric Studies of Protein Structure
- New Algorithms and Software for Mass Spectrometric Analysis of Intact Proteins and Complexes
- Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
Research funding history
13 SBIR/STTR records share this UEI (2012–2021). Reported award amounts total $8,618,687. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services